SABSWSAB Biotherapeutics, Inc.vs its industry peers
A metric-by-metric comparison of SAB Biotherapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SABSW본 종목 | $3M#8 | 0.1x#6 | 0.0x#1 | — | -100.0%#6 | 138.9%#1 | — | 6.2%#1 | — | — | -24.9%#2 | — |
| PMCB | $4M#1 | — | 0.2x#2 | — | — | -163.4%#11 | — | -70.6%#3 | -56.0%#1 | — | -57.3%#3 | — |
| BKHAR | $4M#2 | — | — | — | — | -30.6%#9 | — | — | — | — | — | 1204.0%#1 |
| LIMNW | $4M#3 | — | 12.5x#6 | — | — | -187.8%#12 | — | -3395.2%#6 | -170.3%#3 | — | -65.3%#4 | — |
| CLDI | $3M#6 | 0.0x#3 | 1.0x#5 | 70.6x#6 | — | 10.1%#7 | -44977.8%#7 | -635.4%#5 | — | — | -95.1%#7 | — |
| BCAB | — | 0.1x#5 | — | — | — | -14.6%#8 | -19768.3%#6 | — | — | — | -94.8%#6 | — |
| WINT | $3M#5 | — | — | 17.1x#4 | -88.9%#5 | 91.2%#3 | -13201.5%#5 | — | -308.7%#4 | — | -75.1%#5 | 19.4%#2 |
| ESLAW | $3M#7 | — | — | — | — | — | — | — | — | — | — | — |
| CEROW | $3M#9 | — | — | — | — | — | — | — | — | — | 145.3%#1 | 4.9%#3 |
| SLXN | $2M#10 | 0.0x#2 | 55.3x#7 | — | — | 27.9%#6 | — | -27072.7%#7 | — | — | — | — |
| CRIS | $2M#11 | 0.1x#4 | 0.5x#4 | 0.2x#2 | -13.4%#3 | 82.5%#4 | -60.5%#1 | -161.5%#4 | -87.3%#2 | — | — | — |
| SCLXW | $1M#12 | — | — | 0.0x#1 | -46.5%#4 | -413.8%#13 | -1143.7%#2 | — | — | 4#1 | — | — |
| VIVS | $4M#4 | — | — | 27.3x#5 | -9.0%#2 | -456.4%#14 | -8768.7%#4 | — | — | — | — | — |
| TVGNW | $312554#13 | — | — | — | — | -91.4%#10 | — | — | — | — | — | — |
| JSPRW | $296144#14 | — | 0.2x#3 | — | — | 100.0%#2 | — | -0.0%#2 | — | — | — | — |
| ABPWW | $116152#15 | 0.0x#1 | — | 0.6x#3 | 50.0%#1 | 60.0%#5 | -4618.6%#3 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-20.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice